Apellis Pharmaceuticals (APLS) had the highest return between December 16, 2017 and December 31, 2017 by a mid-cap US stock, returning 66.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Apellis Pharmaceuticals (APLS) | 12/16/2017 - 12/31/2017 | 66.92% |
Appian (APPN) | 12/16/2017 - 12/31/2017 | 46.42% |
Northern Oil & Gas (NOG) | 12/16/2017 - 12/31/2017 | 36.67% |
Consol Energy (CEIX) | 12/16/2017 - 12/31/2017 | 35.31% |
Merus (MRUS) | 12/16/2017 - 12/31/2017 | 30.2% |
Alcoa (AA) | 12/16/2017 - 12/31/2017 | 25.84% |
Equinox Gold (EQX) | 12/16/2017 - 12/31/2017 | 24.52% |
ADMA Biologics (ADMA) | 12/16/2017 - 12/31/2017 | 21.59% |
Crispr Therapeutics (CRSP) | 12/16/2017 - 12/31/2017 | 21.03% |
Embraer SA ADR (ERJ) | 12/16/2017 - 12/31/2017 | 20.62% |
HUTCHMED DRC (HCM) | 12/16/2017 - 12/31/2017 | 20.44% |
Ovintiv (OVV) | 12/16/2017 - 12/31/2017 | 19.02% |
Veren (VRN) | 12/16/2017 - 12/31/2017 | 17.79% |
Xenon Pharmaceuticals (XENE) | 12/16/2017 - 12/31/2017 | 17.46% |
Arrowhead Pharmaceuticals (ARWR) | 12/16/2017 - 12/31/2017 | 16.83% |
Axsome Therapeutics (AXSM) | 12/16/2017 - 12/31/2017 | 16.67% |
Matador Resources (MTDR) | 12/16/2017 - 12/31/2017 | 16.29% |
Vericel Corp Ord (VCEL) | 12/16/2017 - 12/31/2017 | 15.96% |
Exelixis (EXEL) | 12/16/2017 - 12/31/2017 | 15.46% |
Comstock Resources (CRK) | 12/16/2017 - 12/31/2017 | 14.94% |
Corcept Therapeutics (CORT) | 12/16/2017 - 12/31/2017 | 14.89% |
Mr Cooper (COOP) | 12/16/2017 - 12/31/2017 | 14.86% |
Oceaneering International (OII) | 12/16/2017 - 12/31/2017 | 14.46% |
Criteo (CRTO) | 12/16/2017 - 12/31/2017 | 14.07% |
Globalstar (GSAT) | 12/16/2017 - 12/31/2017 | 13.91% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
